On November 4, 2020 Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) reported that it will announce its financial results for the first nine months of 2020 on Thursday, 12 November 2020 (Press release, Evotec, NOV 4, 2020, View Source;announcements/press-releases/p/evotec-se-to-announce-results-for-the-first-nine-months-2020-on-12-november-2020-5992 [SID1234569998]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Company is going to hold a conference call to discuss the results as well as to provide an update on its performance. The conference call will be held in English.

Webcast details

To join the audio webcast and to access the presentation slides you will find a link on our homepage www.evotec.com shortly before the event.

The access code is 315597280#. The on-demand version of the webcast will be available on our website: View Source